MANAGEMENT OF DIABETIC NEUROPATHY

Article Sidebar

PDF
Published: Jul 30, 2003
DOI: https://doi.org/10.21315/
Keywords:
Diabetes Mellitus, Neuropathy, Management

Main Article Content

Raymond Azman Ali
Senior Consultant Neurologist Department of Medicine, Medical Faculty UKM

Abstract

Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.

Article Details

How to Cite
1.
Raymond Azman Ali. MANAGEMENT OF DIABETIC NEUROPATHY. Malays J Med Sci [Internet]. 2003 Jul. 30 [cited 2026 Oct. 19];10(2):27-30. Available from: https://ejournal.usm.my/mjms/article/view/mjms_vol10-no2-2003_4
Issue
Vol. 10 No. 2 (2003)
Section
Review Article
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.